Conflict of Interest in Physician-Industry Relationships

Slides:



Advertisements
Similar presentations
1 Conflicts of interest Different types, different contexts.
Advertisements

Professional Education Support Wyeth Pharmaceuticals Melinda Somasekhar, PhD.
CME 101 The Application Process Sponsored by the Office of Continuing Medical Education.
Physician Relationships with The Pharmaceutical Industry Steven R. Craig, MD, FACP June 22, 2010.
Continuing Professional Development Conflict of Interest This presentation has been developed by the COI Working Group to assist in the implementation.
Integrity and impartiality
The Physician-Pharmaceutical Industry Relationship.
Conflict of Interest (COI) Objectives: Provide an overview of financial conflict of interest (FCOI) related to research activities at Gillette Describe.
Responsible Conduct in Research Conflict of Interest and Commitment.
Promoting Integrity in the Next Generation of Researchers A Curriculum for Responsible Conduct of Research in Occupational Therapy (2005) Funded by the.
Conflict of Interest: Dartmouth College. Why do we care about it ? Conflict of Interest in Research : Unbiased research: design, conduct, reporting Maintain.
National and Institutional Guidelines on Conflict of Interest in Physician-Industry Relationships Rev. 10/21/2014 APGO Interaction with Industry: A Medical.
Pharmaceutical Sales representatives July 2014 Tim Reed Health Action International This document arises from HAI Europe’s Operating Grant 2014, which.
2013 Joint KMS and MSMA CME Provider Conference. The Provider describes that its CME Committee sets the topics and educational goals of its CME activities.
Conflict of Interest. Definition  “A conflict of interest is a situation in which financial or other personal considerations have the potential to compromise.
Conflict of Interest Faculty & Staff of Instruction or Research Human Resources 2011.
Fall 2014 Kate Walker, Vice President for Finance and Treasurer
Towards an Integrity Standard in the Pharmaceutical Industry IACC Conference, May 27, 2003 Seoul, Korea Dr. Jillian Clare Cohen Assistant Professor, Leslie.
A REVIEW FOR ALL PRESENTERS OF ASMBS-SPONSORED EDUCATIONAL ACTIVITIES ASMBS CME Policies, Procedures and Guidelines for Presenters.
Perceptions of Management Issues in Biotechnology in Thailand A Presentation by Associate Prof. Siriyupa Roongrerngsuke, Ph. D. Sarote Phornprapha, Ph.D.
External Influences on Prescribing Practice Karen Ford.
THE ORTHOPAEDIC SURGEON’S RELATIONSHIPS WITH INDUSTRY AAOS ETHICS COMMITTEE Kenneth C. Thomas, MD 1.
Standards for Commercial Support: Standards to Ensure Independence in CME Activities SM Case Studies.
Open Payments Act AKA the ‘Sunshine Act’ Open Payments Act AKA the ‘Sunshine Act’ Public Postings of Physician Ownership, Investments, & Transfers of Value.
Role of Industry in Clinical Care, Research and Education Rev 10/21/2014 APGO Interaction with Industry: A Medical Student Guide.
VCU School of Medicine Policy on Industry Relations Effective July 1, 2009.
Voluntary Codes MassMEDIC Meeting Are You Ready to Comply with Massachusetts’ New Pharmaceutical and Medical Device Code of Conduct Law? Linda D. Bentley,
New Staff Orientation: Industry Relations Emory School of Medicine Zainab R. Wurie, JD July 15, 2014.
 Tracy L. LeGrow, Psy.D. Associate Professor Department of Psychiatry and Behavioral Medicine.
Pitfalls and Lessons Learned: Advanced Implementation Strategies for a Compliant Grant Process National CME Audioconference December 9, 2008.
CONFLICTS OF INTEREST PRESENTED BY THE UMMC OFFICE OF INTEGRITY AND COMPLIANCE.
“Delivering Therapeutic Agents” - Marketing and Communication Strategies of Drug Companies Safura Nantogmah.
Patient, health care and pharmaceutical promotion – a critical inventory Hans-Joachim Both Neurologist, member of IPPNW group Berlin mail adress :
Medicines Transparency Alliance14/10/ Medicines promotion: innovative tools to promote rational use Carole Piriou Project officer Rational use of.
Research Conflicts of Interest: Identifying and Minimizing COI from the Perspective of Faculty July 30, 2009 PonJola Coney, MD Senior Associate Dean for.
+ Conflict of Interest in Physician-Industry Relationships.
Vendor Relations Policy. Why Is There A Policy? The Patient Protection and Affordable Care Act was signed into law March 23, The new law contains.
+ National and Institutional Guidelines on Conflict of Interest in Physician-Industry Relationships.
A Focus on CME and Grants Nancy Coddington, PhD Senior Director, Compliance Operations AstraZeneca Pharmaceuticals LP And Terry Hisey Deputy Managing Principal.
Disclosure of Financial Conflicts of Interest in Continuing Medical Education Michael D. Jibson, MD, PhD and Jennifer Seibert, MD University of Michigan.
Student Affairs Buying 101 Ethics in Buying at OSU Students First Topic
UC DAVIS OFFICE OF RESEARCH Overview of Good Clinical Practices (GCP) Investigator and Study Team Responsibilities Miles McFann IRB Administration Training.
Chapter 3 Research in Psychology: An Ethical Enterprise.
+ Role of Industry in Clinical Care, Research, and Education.
 the study of the rightness or wrongness of human conduct.  In any situation involving two or more individuals, values may come into conflict and ethical.
Partners Conflict of Interest Policy and Reporting October 11, 2012.
The Physician - Pharma Relationship.  Is very old and very close  But are the goals of pharmaceutical companies and medicine the same?
Sara Lovell, CPCS Education Coordinator Providence Alaska Medical Center.
Shelly Rose Ziegler. Overview Gifts from Industry Industry Site Access Academic Activities Questions  Growing external perception that industry has influence.
Lilly Answers that Matter. Preserving the Value of Industry Interactions with Health Care Professionals Jack Harris, M.D. Vice President, U.S. Medical.
Ethics Case 1 Remonte. Rivera, K., Sagayaga. Siy. Talan.
FDA Regulatory and Compliance Symposium Industry Collaboration & Interactions with Health Professionals: Can Conflicts of Interest be Properly Managed?
H ⊕ lger Schünemann, MD, PhD Professor and Chair, Dept. of Clinical Epidemiology & Biostatistics Professor of Medicine Michael Gent Chair in Healthcare.
CME Process and Accreditation Criteria Objectives Explain Updated ACCME Accreditation Criteria Utilize the revised CME Planning Process to incorporate.
Pharmaceutical industry interactions in family medicine residencies have decreased since 2008 Steven R. Brown, MD, David V. Evans, MD, Adriane Fugh-Berman,
ETHICAL ISSUES IN HEALTH AND NURSING PRACTICE CODE OF ETHICS, STANDARDS OF CONDUCT, PERFORMANCE AND ETHICS FOR NURSES AND MIDWIVES.
To Disclose or Not to Disclose That is The Question
The IVD Australia Code of Conduct Edition 2.1
Eimantas Peicius Kaunas regional REC, Lithuania
“Conflicts of Interest”
Neurological Clinicopathologic Case Presentation
Contemporary Paradigms for Anticoagulant Reversal
Unnecessary Procedures- Billing
Continuing Medical education: Principles, concepts, and standards
Medical Professionalism
University of Pittsburgh
Ethics Lecture Conflict of Interest.
Industry Induction Course
Updates to the PhRMA Code on Interactions with Healthcare Professionals National Pharma Audioconference August 5, 2008.
ASMBS CME Policies, Procedures and Guidelines for Presenters
Presentation transcript:

Conflict of Interest in Physician-Industry Relationships APGO Interaction with Industry: A Medical Student Guide Conflict of Interest in Physician-Industry Relationships Rev. 10/21/2014

Objectives Define conflict of interest Recognize situations where conflict of Interest may occur in physician-industry relationships Cite strategies to help manage potential conflicts of interest

Conflict of Interest Definition American Heritage Dictionary: “A conflict between a person's private interests and public obligations.” A potential conflict of interest occurs when there is a possibility that an individuals private interests, or his or her family’s interests, may influence the individual’s professional actions, decisions or judgment. A conflict of interest involves the abuse of trust.

Physician Conflict of Interest Physician (individual) conflict of interest may arise when there is conflict between the interest of the physician and those of his/her patients. Some evidence in literature shows that interactions between physicians and industry representatives, when not properly managed, may lead to the compromising of professional values or negative effects on the physician-patient relationship.

Conflict of Interest Levels Individual Departmental – financial interest of the department has the possibility of influencing the faculty members behavior for the gain of the department Institutional – financial interest of institutional official or institution might appear to affect institutional policies governing the conduct, review and oversight of research. Society – Interest of society may potentially unduly influence some individuals

Example 1: Free Gifts It is a busy day in the office, but you have agreed to speak for a minute to a pharmaceutical representative who has stopped by to drop off some samples of a new quinolone antibiotic called Ubiquinone. Knowing your interest in golf, he has brought you golf balls emblazoned with the letter “U,” and also invites you to a round of golf at the country club this weekend. Would you accept the golf balls? Would you accept the invitation? Would the public know? (From: “Really Difficult Problems in Medical Ethics” and NoFreeLunch presentation)

Physician/Pharmaceutical Relationship Note that in 2012, the pharmaceutical industry spent more than $27 million on marketing to physicians and that 84% of US physicians reported receiving drug samples, payments, meals, other gifts, and/or travel from the pharmaceutical industry. (Pew Prescription Project 2014) Physicians have gradually started to question the ethics and integrities of such interactions as well as the impact drug rep visits have on their prescribing habits and on patients’ health. In 2010, the Sunshine Act was signed into law and requires disclosure to the public of all financial relationships between physicians and medical device companies and pharmaceutical manufacturers.

Example 2: Conflict of Interest You have secured commercial support for your activity from company XYZ. Can the commercial interest (XYZ) give you a list of speakers that could address your topic? Answer: It is ok if they provide a list of potential speakers. Can the commercial interest (XYZ) tell you who must speak or they will not provide support for the program? Answer: No, they cannot tell you who should speak.

Physician-Industry Relationship A physician’s goal is to provide good patient care. Pharmaceutical and medical device companies develop, produce and market drugs and products to treat various ailments or disorders. Their goals include maximizing product sales. Physicians are a main conduit for sales, which have made them an ideal target for marketing strategies. Industry may disseminate information that may not necessarily correspond with information that physicians need. Growth in promotional activities has been accompanied by a rise in industry’s funding of research and education.

Physician-Industry Relationship In 2004, industry spent about $57.5 billion on promotional activities (including $20.4 billion for detailing) In 2007, industry spent $1.2 billion on support for CME accounting for more than half of the costs of formal programs in CME As much as 60% of biomedical research and development is privately funded As many as 70% of clinical trials are funded by pharmaceutical companies

Codes of Ethics Interactions with Industry The Pharmaceutical Research and Manufacturers of America (PhRMA) established the Code on Interactions with Healthcare Professionals in 2002. It was revised in 2009. The American Medical Technology Association (AdvaMed) created the Code of Ethics on Interactions with Health Care Professionals in 2003. It was also revised in 2009. These codes are reviewed frequently.

Physician-Industry Relationships Examples of industry practices which can create conflict of interest: Food Gifts (pens, books) Drug samples Support of medical education activities Speakers bureaus and consulting fees Research grants Contact with trainees can begin early and follows as physicians move to practice

Reality Check Prescribing practices of physicians may be influenced by both subtle and obvious marketing messages and gifts. Physicians may not recognize or admit to any changes in their practice of medicine due to these influences. In a study of medical residents, 61% were confident that drug companies did not influence their practice, while only 16% were equally confident that their colleagues were unaffected by those practices. (Ref: Am J Med 110:2001;551- 557)

Students Interactions with Industry Medical student-industry interactions can be common. Students may tend to be permissive regarding the acceptance of gifts. Students underestimate the influence of gifts may have on their behavior. It is important as a student to understand physician-industry relationships and the potential risk for conflict of interest.

Reality Check - Medical Students In 2011, a comprehensive review of US medical students reported: 89 - 98% were asked to attend at least one sponsored lunch 90% received educational materials from industry 69% believed gifts would not influence their practice 80% believed they were entitled to gifts 86% of the students who thought gifts of a certain amount were inappropriate had accepted one (Austad et al PLoS Med 8:e10001037; 2011)

National Survey Shows Medical Students and Residents Have Frequent Interactions with Pharmaceutical Companies 40%–100% of medical students reported interactions 13%–69% reported belief that industry gifts influence prescribing Eight studies reported correlation between frequency of contact and favorable attitudes. Students were more approving of gifts to physicians or medical students than to government officials. Certain attitudes appeared to change during medical school Clinical students (53%–71%) more likely than pre-clinical students (29%–62%) to report that promotional information helps to educate about new drugs.

“To maintain integrity and independent-decision making, physicians must ensure that they maintain an impartial relationship with industry representatives free of any influences.”

Managing Conflict of Interest Strategy for managing conflict of interest : Recognition Disclosure Management

Recognition Physicians need to recognize that gifts, regardless of the value, may influence behavior and a self-serving bias distorts the way individuals perceive themselves. Conflict of interest policies are developed to help individuals recognize potential conflict of interest situations. Physicians need to be aware of laws, ethical guidelines and their institutional policies and follow them.

Disclosure Disclosure: Financial relationships with industry Research funding and sponsored studies BUT Good intentions are not sufficient given the problem of perception v. reality. Therefore, when a conflict of interest is reported, it needs to be carefully reviewed by the appropriate individuals or committee.

Disclosure Interpretation Studies show that the disclosure of a competing interest in an article affects readers’ perceptions of its interest, importance, validity, relevance and believability. Assessment of the quality of the article provides important information (CONSORT statement).

Management Eliminate practices that have little or no added clinical value (e.g. gifts, free lunches). To be free from commercial bias: if one product is mentioned, then all options should be discussed. Manage reported conflict of interest to minimize or eliminate the conflict: Public disclosure Independent review Modifying research plan Disqualifying participation

Summary Physicians should be aware that conflict of interest may exist in their relationships with industry if relationships are not properly managed. Physicians should learn to eliminate or reduce these conflicts in the interest of their patients. Become familiar with your organization’s conflict of interest and industry relations policies. See also APGO’s Industry Relations Policy as a reference. https://www.apgo.org/about/industry.html (hyperlink will be active in presentation mode)

Resources (hyperlinks will be active in presentation mode) APGO Industry Relations Policy (https://www.apgo.org/about/industry.html) American Association of Medical Colleges (http://www.aamc.org/research/coi) Association of American Universities (http://www.aau.edu/research/conflict.cfm) Council on Government Relations, Financial Conflicts of Interest (http://www.cogr.edu/docs/COIFinal.pdf) National Institutes of Health (http://grants.nih.gov/grants/policy/coifaq.htm) PhRMA Code http://www.phrma.org/principles-guidelines/code-on-interactions-with-health- care-professionals) AdvaMed Code (http://advamed.org/issues/1/code-of-ethics)